Get the Stockscreener App
10.88
37.90%
2.99
After Hours:
10.90
0.02
+0.18%
Eyenovia Inc stock is traded at $10.88, with a volume of 6.01M.
It is up +37.90% in the last 24 hours and up +601.94% over the past month.
Eyenovia Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies that target new indications or new combinations.
See More
Previous Close:
$7.89
Open:
$8.38
24h Volume:
6.01M
Relative Volume:
2.19
Market Cap:
$11.76M
Revenue:
$31,800
Net Income/Loss:
$-37.83M
P/E Ratio:
-15.32
EPS:
-0.71
Net Cash Flow:
$-30.64M
1W Performance:
+158.43%
1M Performance:
+601.94%
6M Performance:
+44.37%
1Y Performance:
-80.35%
1-Day Range:
$8.04
$12.37
1-Week Range:
$4.57
$12.37
52-Week Range:
$0.85
$124.80
Eyenovia Inc Stock (EYEN) Company Profile
Name
Eyenovia Inc
Sector
Industry
Phone
813-766-9539
Address
295 MADISON AVENUE,, NEW YORK, NY
Compare EYEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EYEN
Eyenovia Inc
|
10.88 | 11.76M | 31,800 | -37.83M | -30.64M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.30 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
521.00 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.83 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
560.14 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
241.20 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Eyenovia Inc Stock (EYEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-18-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-01-21 | Initiated | Northland Capital | Outperform |
| Feb-03-20 | Downgrade | Oppenheimer | Outperform → Perform |
Eyenovia Inc Stock (EYEN) Latest News
HYPE Price Drops Below $40 Despite $50M Eyenovia Investment - The Currency analytics
Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings - The Malaysian Reserve
Eyenovia Bets On Crypto Hype To Revive Struggling Stock - FinanceFeeds
Eyenovia (EYEN) Advances Digital Strategy with Key Developments - GuruFocus
$50 Million Gamble or Genius Move? Eyenovia’s Big Blockchain Bet - Bitcoin.com News
Eyenovia (EYEN) Advances Digital Strategy with Key Developments | EYEN Stock News - GuruFocus
Eyenovia secures debt restructuring as it builds HYPE token treasury By Investing.com - Investing.com Nigeria
Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group | EYEN Stock News - GuruFocus
Eyenovia appoints strategic advisor for digital asset treasury strategy - TipRanks
Eyenovia Announces Appointment of a Strategic Advisor for - GlobeNewswire
Eyenovia Secures Major Win: 33% Lower Interest Rate and Top Crypto Advisor Join Forces - Stock Titan
Hyperliquid price outlook amid Eyenovia’s $50M HYPE treasury strategy - CoinJournal
Top Premarket Decliners - MarketScreener
Eyenovia unveils $50M HYPE token strategy; shares drop - MSN
Eyenovia (EYEN) Secures $50 Million Private Placement for Blockchain Initiative - GuruFocus
Eyenovia to invest $50M in Hyperliquid tokens - MSN
Eyenovia Launches $50 Million HYPE Treasury, Announces Rebrand to Hyperion DeFi - BeInCrypto
Nasdaq-Listed Eyenovia Announces to Add $HYPE in Treasury Reserve - The Crypto Times
HYPE drops 6% amid Eyenovia plans to establish Hyperliquid treasury - FXStreet
Eyenovia (EYEN) Secures $50M to Boost Blockchain Initiative | EY - GuruFocus
Eyenovia Invests $50 Million to Establish HYPE Reserve, Company Will Change Name to 'Hyperion DeFi' - Binance
Eyenovia stock soars after $50 million investment for cryptocurrency strategy By Investing.com - Investing.com Nigeria
Eyenovia Inc Announces $50 Million Private Placement In Public Equity - marketscreener.com
Eyenovia (EYEN) Secures $50M Investment for Blockchain Expansion | EYEN Stock News - GuruFocus
Eyenovia to acquire $50 million in HYPE cryptocurrency tokens - Investing.com
Eyenovia to acquire $50 million in HYPE cryptocurrency tokens By Investing.com - Investing.com India
Eyenovia to change name to Hyperion DeFi, ticker to ‘HYPD’ - TipRanks
Eyenovia announces $50M PIPE financing to launch Hyperliquid reserve strategy - TipRanks
Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy | EYEN Stock News - GuruFocus
Eyenovia Announces $50 Million Investment to Launch a - GlobeNewswire
Formosa Pharmaceuticals grants Harrow US commercial rights to clobetasol propionate ophthalmic suspension 0.05% (BYQLOVI), terminates deal with Eyenovia - Ophthalmology Times
Eyenovia (EYEN) Stock Skyrockets Over 23% on Nasdaq, Showing Explosive Short-Term Rally - Daily Chhattisgarh News
Eyenovia (EYEN) Stock Explodes Following Amended Loan Agreement Terms: What's Going On? - Benzinga
eyenovia amends loan agreement, limits stock conversion option By Investing.com - Investing.com Canada
Eyenovia On May 30, Enters Third Amendment To Loan And Security AgreementSEC Filing - MarketScreener
eyenovia amends loan agreement, limits stock conversion option - Investing.com
Eyenovia Amends Loan Agreement with Avenue Capital - TipRanks
Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities - GlobeNewswire Inc.
Larry Childress buying at Fireweed Metals (FWZ) - The Globe and Mail
Eyenovia provides update on potential merger and Optejet development - MSN
Eyenovia Provides Updates on Potential Merger with Betaliq and D - GuruFocus
Eyenovia Advances Merger Talks With Betaliq And Targets FDA Filing For Optejet Device - Nasdaq
Why Pegasystems Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket - Benzinga
Eyenovia Reports Q1 2025 Progress and Financials - TipRanks
Eyenovia advances on merger talks, cuts cash burn, eyes September FDA filing By Investing.com - Investing.com South Africa
Eyenovia advances on merger talks, cuts cash burn, eyes September FDA filing - Investing.com Australia
Eyenovia Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Eyenovia (EYEN) Pursues Merger with Betaliq and Advances Optejet Device | EYEN Stock News - GuruFocus
Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results | EYEN Stock News - GuruFocus
Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results - The Manila Times
Eyenovia, Inc. Provides Merger Update with Betaliq and Financial Results for Q1 2025 - Nasdaq
Eyenovia Inc Stock (EYEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Eyenovia Inc Stock (EYEN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Rowe Michael M | Chief Executive Officer |
Aug 26 '24 |
Buy |
0.57 |
50,000 |
28,500 |
82,927 |
| Grant Stuart M. | 10% Owner |
Jul 02 '24 |
Buy |
0.66 |
1,515,151 |
1,000,000 |
10,914,153 |
1.11%
1.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):